ClinVar Miner

Submissions for variant NM_003482.4(KMT2D):c.16522-5_16522-2del

dbSNP: rs2137703007
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV001733827 SCV001984814 pathogenic Kabuki syndrome 1 2020-08-12 criteria provided, single submitter clinical testing This variant affects the canonical splice acceptor site of intron 53 and is therefore predicted to interfere with splicing and result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has not been previously reported or functionally characterized in the literature to our knowledge. This alteration is located at the C-terminal portion of KMT2D that includes the SET domain with histone methyltransferase activity (PMID: 28669924). Other splicing alterations within intron 53 have been reported in individuals with Kabuki Syndrome (PMID: 28475860, 29304373). This variant is absent from the gnomAD population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.16522-5_16522-2del variant is classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.